Lipid Nanoparticulate Drug Delivery And Nanomedicine

Heidi - Mansour, Yun Seok Rhee, Chun Woong Park, Patrick P. DeLuca

Research output: Chapter in Book/Report/Conference proceedingChapter

16 Citations (Scopus)

Abstract

Nanomedicine, as a convergence of nanoscience with molecular pharmaceutics and medicinal science, is currently one of the fastest growing aspects of nanotechnology and will be for the foreseeable future. It is essential for physiological understanding of living targets based on biological science and for developing multifunctional nanomaterials as drug delivery carriers with novel nanotechnology. Nanomedicines can be designed for solubilization of lipophilic drugs that are poorly water-soluble, thereby improving drug absorption in the body, and for drug-targeting at the cellular and molecular level, which offers enhanced therapeutic effects and decreased side effects. The approaches that have progressed rapidly in nanomedicine and drug delivery are the lipid-based nanoparticulate drug delivery systems, such as Solid Lipid Nanoparticles (SLNs), Nanostructure Lipid Carriers (NLCs), and liposomal drug delivery carriers. SLN, NLC, and liposomal carrier systems are attractive carriers for nanomedicines and drug delivery. SLNs themselves represent a solid technology whereas NLCs are comprised of liquid lipid in a solid matrix. Liposomal drug delivery carriers are bio-membrane colloidal dispersion systems in an aqueous bulk phase. Proliposomes are solid-state formulation of dry, free-flowing particles, which have the ability to form liposomal colloidal dispersions following hydration. Despite the fact that the use of lipid nanoparticulate drug delivery for nanomedicine is very promising and a highly attractive application platform, further basic research needs to be done in this exciting area.

Original languageEnglish (US)
Title of host publicationLipids in Nanotechnology
PublisherElsevier Inc.
Pages221-268
Number of pages48
ISBN (Print)9780128043455, 9780981893679
DOIs
StatePublished - Sep 3 2011
Externally publishedYes

Fingerprint

Nanomedicine
Medical nanotechnology
Drug delivery
Lipids
Drug Carriers
Nanostructures
Pharmaceutical Preparations
Nanoparticles
Nanotechnology
Drug Delivery Systems
Nanoscience
Biological Science Disciplines
Therapeutic Uses
Dispersions
Nanostructured materials
Hydration
Technology
Membranes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Mansour, H. ., Rhee, Y. S., Park, C. W., & DeLuca, P. P. (2011). Lipid Nanoparticulate Drug Delivery And Nanomedicine. In Lipids in Nanotechnology (pp. 221-268). Elsevier Inc.. https://doi.org/10.1016/B978-0-9818936-7-9.50012-3

Lipid Nanoparticulate Drug Delivery And Nanomedicine. / Mansour, Heidi -; Rhee, Yun Seok; Park, Chun Woong; DeLuca, Patrick P.

Lipids in Nanotechnology. Elsevier Inc., 2011. p. 221-268.

Research output: Chapter in Book/Report/Conference proceedingChapter

Mansour, H, Rhee, YS, Park, CW & DeLuca, PP 2011, Lipid Nanoparticulate Drug Delivery And Nanomedicine. in Lipids in Nanotechnology. Elsevier Inc., pp. 221-268. https://doi.org/10.1016/B978-0-9818936-7-9.50012-3
Mansour H, Rhee YS, Park CW, DeLuca PP. Lipid Nanoparticulate Drug Delivery And Nanomedicine. In Lipids in Nanotechnology. Elsevier Inc. 2011. p. 221-268 https://doi.org/10.1016/B978-0-9818936-7-9.50012-3
Mansour, Heidi - ; Rhee, Yun Seok ; Park, Chun Woong ; DeLuca, Patrick P. / Lipid Nanoparticulate Drug Delivery And Nanomedicine. Lipids in Nanotechnology. Elsevier Inc., 2011. pp. 221-268
@inbook{f7606327b7cf4ffc9a3c675a494065c2,
title = "Lipid Nanoparticulate Drug Delivery And Nanomedicine",
abstract = "Nanomedicine, as a convergence of nanoscience with molecular pharmaceutics and medicinal science, is currently one of the fastest growing aspects of nanotechnology and will be for the foreseeable future. It is essential for physiological understanding of living targets based on biological science and for developing multifunctional nanomaterials as drug delivery carriers with novel nanotechnology. Nanomedicines can be designed for solubilization of lipophilic drugs that are poorly water-soluble, thereby improving drug absorption in the body, and for drug-targeting at the cellular and molecular level, which offers enhanced therapeutic effects and decreased side effects. The approaches that have progressed rapidly in nanomedicine and drug delivery are the lipid-based nanoparticulate drug delivery systems, such as Solid Lipid Nanoparticles (SLNs), Nanostructure Lipid Carriers (NLCs), and liposomal drug delivery carriers. SLN, NLC, and liposomal carrier systems are attractive carriers for nanomedicines and drug delivery. SLNs themselves represent a solid technology whereas NLCs are comprised of liquid lipid in a solid matrix. Liposomal drug delivery carriers are bio-membrane colloidal dispersion systems in an aqueous bulk phase. Proliposomes are solid-state formulation of dry, free-flowing particles, which have the ability to form liposomal colloidal dispersions following hydration. Despite the fact that the use of lipid nanoparticulate drug delivery for nanomedicine is very promising and a highly attractive application platform, further basic research needs to be done in this exciting area.",
author = "Mansour, {Heidi -} and Rhee, {Yun Seok} and Park, {Chun Woong} and DeLuca, {Patrick P.}",
year = "2011",
month = "9",
day = "3",
doi = "10.1016/B978-0-9818936-7-9.50012-3",
language = "English (US)",
isbn = "9780128043455",
pages = "221--268",
booktitle = "Lipids in Nanotechnology",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Lipid Nanoparticulate Drug Delivery And Nanomedicine

AU - Mansour, Heidi -

AU - Rhee, Yun Seok

AU - Park, Chun Woong

AU - DeLuca, Patrick P.

PY - 2011/9/3

Y1 - 2011/9/3

N2 - Nanomedicine, as a convergence of nanoscience with molecular pharmaceutics and medicinal science, is currently one of the fastest growing aspects of nanotechnology and will be for the foreseeable future. It is essential for physiological understanding of living targets based on biological science and for developing multifunctional nanomaterials as drug delivery carriers with novel nanotechnology. Nanomedicines can be designed for solubilization of lipophilic drugs that are poorly water-soluble, thereby improving drug absorption in the body, and for drug-targeting at the cellular and molecular level, which offers enhanced therapeutic effects and decreased side effects. The approaches that have progressed rapidly in nanomedicine and drug delivery are the lipid-based nanoparticulate drug delivery systems, such as Solid Lipid Nanoparticles (SLNs), Nanostructure Lipid Carriers (NLCs), and liposomal drug delivery carriers. SLN, NLC, and liposomal carrier systems are attractive carriers for nanomedicines and drug delivery. SLNs themselves represent a solid technology whereas NLCs are comprised of liquid lipid in a solid matrix. Liposomal drug delivery carriers are bio-membrane colloidal dispersion systems in an aqueous bulk phase. Proliposomes are solid-state formulation of dry, free-flowing particles, which have the ability to form liposomal colloidal dispersions following hydration. Despite the fact that the use of lipid nanoparticulate drug delivery for nanomedicine is very promising and a highly attractive application platform, further basic research needs to be done in this exciting area.

AB - Nanomedicine, as a convergence of nanoscience with molecular pharmaceutics and medicinal science, is currently one of the fastest growing aspects of nanotechnology and will be for the foreseeable future. It is essential for physiological understanding of living targets based on biological science and for developing multifunctional nanomaterials as drug delivery carriers with novel nanotechnology. Nanomedicines can be designed for solubilization of lipophilic drugs that are poorly water-soluble, thereby improving drug absorption in the body, and for drug-targeting at the cellular and molecular level, which offers enhanced therapeutic effects and decreased side effects. The approaches that have progressed rapidly in nanomedicine and drug delivery are the lipid-based nanoparticulate drug delivery systems, such as Solid Lipid Nanoparticles (SLNs), Nanostructure Lipid Carriers (NLCs), and liposomal drug delivery carriers. SLN, NLC, and liposomal carrier systems are attractive carriers for nanomedicines and drug delivery. SLNs themselves represent a solid technology whereas NLCs are comprised of liquid lipid in a solid matrix. Liposomal drug delivery carriers are bio-membrane colloidal dispersion systems in an aqueous bulk phase. Proliposomes are solid-state formulation of dry, free-flowing particles, which have the ability to form liposomal colloidal dispersions following hydration. Despite the fact that the use of lipid nanoparticulate drug delivery for nanomedicine is very promising and a highly attractive application platform, further basic research needs to be done in this exciting area.

UR - http://www.scopus.com/inward/record.url?scp=84863488316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863488316&partnerID=8YFLogxK

U2 - 10.1016/B978-0-9818936-7-9.50012-3

DO - 10.1016/B978-0-9818936-7-9.50012-3

M3 - Chapter

AN - SCOPUS:84863488316

SN - 9780128043455

SN - 9780981893679

SP - 221

EP - 268

BT - Lipids in Nanotechnology

PB - Elsevier Inc.

ER -